NCPR is supported by:

|
4 min., 45 sec.
|
Programs
Latest program rundownComing up:
Latest Features:
May 24, 2013 | NPR ·
May 24, 2013 | NPR ·
May 24, 2013 | NPR ·
Latest program rundownComing up:
Latest Features:
May 25, 2013 | NPR ·
May 25, 2013 | NPR ·
May 25, 2013 | NPR ·
Latest Saturday rundownWE Saturday Feature
May 25, 2013 | NPR ·
Latest Sunday rundown
WE Sunday Feature
May 19, 2013 | NPR ·
Advertising
Feb 22, 2012 — Advertisers collect information with every digital move people make. They then target ads based on that information. Communications scholar Joseph Turow worries that advertisers will use such data to discriminate against people and put them into "reputation silos."
Nov 14, 2010 — Roger Sterling may be the show's most charismatic and lovable characters. His memoir, once a book that existed only in the show's fictional universe, is now real enough to find in your Christmas stocking.
Jul 24, 2010 — Before there was Mad Men, there was From Those Wonderful Folks Who Gave You Pearl Harbor, the cultish and colorful advertising memoir by 1960s ad man Jerry Della Femina that also served as inspiration for AMC's hit series.
Apr 24, 2010 — Ad man Terry O'Reilly is behind the Canadian radio show and new book The Age of Persuasion. He uses his insider perspective to dissect the world of advertising.
Sep 23, 2009 — Former adman James Othmer spent two decades working in the ad industry as it was in the throes of a dramatic transformation. As more consumers zap commercials on DVRs and read magazines and newspapers online, Othmer has concluded that the Madison Avenue industry as he knew it is dying.
Feb 3, 2006 — Some 130 million people are expected to watch Super Bowl XL on Sunday. As always, advertisers are paying big bucks to grab viewers' attention — and some have resorted to making their spots as strange or unpredictable as possible, says author Warren Berger in his book, Advertising Today.
Oct 16, 2004 — Dr. Marcia Angell is the author of The Truth About Drug Companies. Angell, former editor of the New England Journal of Medicine, disputes drug firms' claims that prices are high because profits are used for research and development. Hear Angell and NPR's Jennifer Ludden.


on:






